References
- Maki DG, Goldmann DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med 1973; 79: 867
- Armstrong CW, Mayhall CG, Miller KB, et al. Prospective study of catheter replacement and other risk factors for infection of hyperlimentation catheter. J Infect Dis 1986; 154: 808–816
- Ryan JA, Abel RM, Abbott WM, et al. Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patients. N Engl J Med 1974; 290: 757–761
- Sheretz RJ, Falk RJ, Huffman KA, Thomann CA, Mattern WD. Infections associated with subclavian Uldall catheters. Arch Intern Med 1983; 143: 52–56
- Raad IR, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15: 197–210
- Clarke DE, Raffin TA. Infectious complications of indwelling long term central venous catheters. Chest 1990; 97: 966–72
- Arrowgard International, Inc. 1994, Reading, PA
- Maki DG, Stolz SM, Wheeler S, Mermel LA. Clinical trial of a novel antiseptic coated central venous catheter. Abstract No. 461. October, 1991, ICAAC, Chicago
- Greenfield J, Sampath L, Modak S, Baradarian R, Stylianos S, Modak S. Intravascular placement of silver sulfadiazine/chlorhexidine impregnated catheters (SCC) in swine: Evaluation of biofilm (BF) formation and bacterial adherence (BA). ICAAC, New Orleans October, 1993, Abstract No. 1620
- Bach A, Geiss M, Geiss HK, Sonntag HG. Prevention of colonization of central venous catheters by silver-sulfadiazine-chlorhexidine (SCC) bonding: Results of a pilot study in critical care patients. Abstract No. 1621, ICAAC, New Orleans October, 1993
- Clemence MA, Jernigan JA, Titus MA, Duani DK, Farr BM. A study of an antiseptic impregnated central venous catheter for prevention of bloodstream infection. Abstract No. 1624, ICAAC, New Orleans October, 1993
- Maki D, Weise CE, Safafin HW. A semiquantitative culture method for identifying intravenous catheter-related infection. N Engl J Med 1977; 296–1305